Interior Banner 6

FDL Resources

  • 6,000 sq. ft. lab & office space
  • Wet lab (BL-2)
  • Biosafety Cabinets (5)
  • CO2 incubators (14)
  • Plate Readers (2)
  • Liquid Handling Robotics (5)
  • Gel Imager
  • rt qPCR
  • Ussing Chambers (3 x 8)
  • Automated Conductance Assay
  • Electroporation
  • Cell counter
  • Fluorescent Microscope
  • NMR & LC-MS access
  • Chemi/Bio-Informatics

News & Developments

Oct 10, 2013 Flatley Discovery Lab, LLC Nominates Clinical Candidate for Treatment of Cystic Fibrosis
CHARLESTOWN, Mass.--(PRESS ENTITY)—October 10, 2013—Flatley Discovery Lab, LLC today announced that it has nominated FDL169, an orally available small molecule for the treatment of Cystic Fibrosis, as a clinical candidate and initiated IND-enabling st
Dec 3, 2012 Hub lab seeks wider cystic fibrosis cure
Word last week that the U.S. Food and Drug Administration had approved a drug developed by a Cambridge biotech company to treat a rare form of cystic fibrosis that affects about 1,200 people upped the ante for a lab in neighboring Charlestown...
Dec 3, 2012 Venture firm backs start-ups targeting cystic fibrosis
John Flatley, a real estate developer and philanthropist, has founded an investment group called Flatley Venture Capital to back life sciences start-ups with potential treatments for the genetic disease cystic fibrosis. Flatley, who has a close relative w
Dec 3, 2012 WHOI teaming with Flatley Discovery Lab in search for effective treatments for cystic fibrosis.
The Woods Hole Oceanographic Institution (WHOI) has signed a $1.18 million agreement with the Flatley Discovery Lab in Charlestown, Mass., to investigate and supply marine microbial extracts as possible treatments for cystic fibrosis (CF).